G/SPS/GEN/1494  
 
17 June 2016  
(16-3315)  Page: 1/9  
Committee on Sanitary and Phytosanitary Measures  Original: English  
 
ON-GOING REVIEW OF MA XIMUM RESIDUE LEVELS 
OF PESTICIDES IN THE EUROPEAN UNION 
COMMUNICATION FROM THE EUROPEAN UNION 
The following communication, received on 16 June 2016, is being circulated at the request of the 
Delegation of the European Union. 
 
_______________ 
  
This note is addressed to countries outside the European Union (EU). It explains the on-going 
process in the European Union to review th e current maximum residue levels (MRLs) for 
pesticides. It describes how non-EU countries can actively contribute to the reviewing process. 
 
Non-EU countries may submit additional data to the EU risk assessors, should they wish to support 
specific uses of pesticides that are no longer approved in the European Union. This note highlights 
the specific stages in the review process when non-EU countries may send such additional data. 
 
The note also includes the list of the active substances subject to the review process. 
 
1  THE REVIEW PROCESS OF THE EXISTING EU PESTICIDE MRLS 
1.1.  Article 12 of Regulation (EC) 396/20051 provides for a mechanism to review the existing 
maximum residue levels (MRLs) of all approved and certain non-approved pesticides. This review process has been on-going since 2008. 
1.2.  For each active substance, one member State of the European Union is designated as 
"Rapporteur Member State" (RMS). The RMS carri es out the first evaluation of the existing 
EU pesticide MRL and prepares an evaluation report recommending its amendment if necessary. 
1.3.  Subsequently, the scientific risk assessment body of the European Union, the European Food 
Safety Authority (EFSA), is charged with deliverin g a reasoned opinion on each substance, based 
on the evaluation report prepared by the RMS. The opinions are published on the EFSA webpage: 
http://www.efsa.europa.eu/en/ publications/efsajournal ). Using the search function and the name 
of the substance, the relevant opinion can be easily retrieved. 
1.4.  The European Commission (Commission) considers the opinion of EFSA and initiates a 
discussion with the EU member States about the appropriate risk management measures to be 
taken in case of certain substances, i.e. possible modification of certain MRLs. The Commission 
also consults the network of the European Union reference laboratories on analytical aspects and takes into account other scientific information available on the specific substance. 
1.5.  On this basis the Commission prepares a draf t proposal in which amendments to the existing 
pesticide MRLs are proposed. The draft proposal is discussed with delegates of the EU member 
States in a regulatory Committee (Standing Committee on Plants, Animals, Food and Feed, shortly 
                                               
1 Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on 
maximum residue levels of pesticides in or on food and feed of plant an d animal origin and amending Council 
Directive 91/414/EEC. G/SPS/GEN/1494 
 
- 2 - 
 
  "PAFF Committee"). The PAFF Committee meets several times a year, is chaired by the 
Commission and comprised of the representatives of the 28 EU member States. 
1.6.  Before being discussed in the PAFF Committee, the draft proposal is also notified to WTO 
Members through the WTO/SPS Secretariat. WTO Members have 60 calendar days to comment on 
the Commission proposal. 
1.7.  The PAFF Committee takes into consideration all comments received and votes on the 
Commission proposal. Once endorsed by the PAFF Committee, the proposal is scrutinized by the 
Council of the European Union and by the European Parliament during a two month-period. If the 
two institutions do not object in that timeframe, the proposal is finally adopted by the Commission as a legislative act. 
1.8.  It is then translated into the official languages of the European Union and published in the 
Official Journal of the European Union. 
2  WHEN AND HOW CAN NON-EU COUNTRIES INTERVENE IN THE REVIEW PROCESS? 2.1.  Authorities of non-EU countries may intervene in the review process described above at two 
different stages: at an early stage (box 1) and at a later stage (box 2). 
1) At an early stage, via the Rapporteur Member State (RMS): 
Non-EU countries which wish to submit additional supporting information or data on a specific 
active substance in which they may have a special interest, can submit such information at an 
early stage of the process, before the risk assessment is carried out by EFSA. 
 
Non-EU countries should first contact the manufac turer of the active substance concerned. They 
then need to submit the additional data through the manufacturer to the EU member State, which 
has been appointed as "Rapporteur Member State" for that active substance. The RMSs for each 
active substance are listed in the third column of Table 1 and 2, attached to this note. 
 
2) During the WTO/SPS co nsultation procedure: 
Before being submitted for a vote in the PAFF Committee, draft proposals of the Commission 
amending existing pesticide MRLs are notified  under the SPS Agreement of the World Trade 
Organisation. 
 
WTO members have 60 calendar days to send their comments to the SPS contact point of the 
European Union. Received comments are consider ed by the Commission before the vote takes 
place at the PAFF Committee. 
 
2.2.  Non-EU countries which have a special interest in a particular active substance may intervene 
at one or both stages explained above. It is however strongly advised and in the interest of the country to intervene at the early stage of the procedure. 
2.3.  Non-EU countries are therefore invited to consult the lists of active substances for which the 
review process is already planned (see paragraph 4) and to provide as soon as possible the additional data to the RMS in charge. 
3  WHAT HAPPENS IF NON-EU COUNTRIES DO NOT INTERVENE AT ANY STAGE? 
3.1.  The review process of the existing EU pesticide MRLs proceeds as described in point 1. For 
the protection of consumers, the European Union sets MRLs as low as reasonably achievable. Therefore, in the absence of any additional information from non-EU countries, MRLs may in some 
cases be lowered to a level that has a negative impact on exports of the relevant commodity from 
non-EU countries into the European Union. 
3.2.  If deemed necessary for ensuring the continui ty of international trade, after the publication of 
new MRLs, non-EU countries may submit a specific "import tolerance" request. The request must 
be addressed to the RMS for the active substance. G/SPS/GEN/1494 
 
- 3 - 
 
  3.3.  Import tolerance requests normally concer n  M R L s  o f  a c t i v e  s u b s t a n c e s  a p p r o v e d  i n  t h e  
European Union, but they may be introduced also for active substances that are not anymore approved in the European Union, provided that a ll the required data on the active substance are 
submitted. More details on the procedure of the "import tolerance" are given in Article 6.4 of 
Regulation (EC) No 396/2005. 
3.4.  In case of a positive evaluation of the data submitted by the non-EU country, the European 
Union may launch a procedure to amend the MRL. It must be considered that it may take one to 
two years from the submission of the request unt il the entering into force of the amended MRL. 
4  WHEN AND FOR WHICH AC TIVE SUBSTANCES IS THE REVIEW PROCESS PLANNED? 
4.1.  Table 1 and 2 attached to this note contain the lists of the active substances for which the 
review process is already planned (situation updated as of 8 March 2016). These two lists are 
accessible on the EFSA website (where they are called Appendixes B2 and B3) and regularly 
updated. Non-EU countries authorities are invited to consult the following link to access the most 
updated lists: http://www.efsa.europa.eu/sites/d efault/files/event/140619ax1.pdf . 
4.2.  The active substances listed in Table 1 will be evaluated by EFSA in 2016 and in the first 
quarter of 2017, according to a procedure called " interim process ". Some of the evaluations have 
already been completed as indicated in the footnote s. The active substances listed in Table 2 will 
be evaluated later, starting from the second quarter of 2017, under the " future process ". 
The order in the tables corresponds to the order in which the evaluation of the active substance is planned. It should be considered as indicative. Emerging priorities may require adapting the order of evaluation at any stage. 
4.3.  The differences between the interim  and future  processes are mainly procedural. They are 
further explained at: http://www.efsa.europa.eu/sites/d efault/files/event/140619-m.pdf , in the 
chapter " Agenda item 5.1: Streamlining the review of MRLs under Art. 12 of Regulation (EC) 
No 396/2005 ". 
4.4.  In the third column of Table 1 and 2 th e RMS responsible for each active substance is 
indicated. The list of the national contact points can be found at:  
http://ec.europa.eu/food/plant/pesticides/legislation/docs/national-authorities_en.pdf . 
5  BACKGROUND: THE EU LEGISLATION ON PESTICIDES 
5.1.  The principles of the EU legislation on pesticides are laid down in three main legislative acts: 
 Regulation (EC) No 1107/20092, provides rules on the pl acing of plant protection 
products on the market; 
 Regulation (EC) No 396/2005, already mentioned, provides details on the maximum 
residue levels of pesticides (MRLs) in or on food and feed of plant and animal origin; 
 Directive 2009/128/EC3, sets rules for the sustainable use of pesticides to reduce the 
risks and impacts of their use on people's health and the environment. 
5.2.  EU legislation foresees that each active su bstance intended to be used in the European Union 
as a plant protection product (commonly called 'pesticide') first needs to be approved. The 
approval of active substances is granted at EU level. Further details can be found at: http://ec.europa.eu/food/plant/pesticides/ approval_active_substances/index_en.htm  
5.3.  Along with the first approval of the active substance, specific maximum residue levels (MRLs) 
considered as safe for the consumers need to be established. This procedure is further described 
at: http://ec.europa.eu/food/plant/pesticides/max_residue_levels/index_en.htm  
                                               
2 Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 
concerning the placing of plant protection products on  the market and repealing Council Directives 79/117/EEC 
and 91/414/EEC. 
3 Directive 2009/128/EC of the European Parliament and of the Council of 21 October 2009, establishing 
a framework for Community action to achi eve the sustainable use of pesticides. G/SPS/GEN/1494 
 
- 4 - 
 
  5.4.  The plant protection products containing EU approved active substances can only be placed 
on the EU market after prior authorisation. The authorisation of plant protection products is 
granted by the EU member States. Further details can be found at:  http://ec.europa.eu/food/plant/pestici des/authorisation_of_ppp/index_en.htm  
6  FURTHER INFORMATION 
6.1.  For any further information, interested parties may consult the section of the European 
Commission website specifically dedicated to pesticides: 
http://ec.europa.eu/food/plant/pesticides/index_en.htm  
 
 G/SPS/GEN/1494 
 
- 5 - 
 
  TABLE 1 
ACTIVE SUBSTANCES WHICH WILL BE REVIEWED UNDER THE " INTERIM " PROCESS 
Foreseen timeframe: the active substances listed in  this table will be evaluated in 2016 and in the 
first quarter of 2017. The order corresponds to th e planned order of evaluation of the active 
substances. It should be considered as indicative. In case of emerging priorities the order of 
evaluation of the substances may need to be amended.  
This table was updated on 8 March 2016. Non-EU countries authorities are invited to consult the 
following EFSA link to access always the most updated version: http://www.efsa.europa.eu/sites/d efault/files/event/140619ax1.pdf . 
 
EFSA-Q-number (*) Active substance RMS 
EFSA-Q-2008-511  Cinidon-ethyl (a)  UNITED KINGDOM  
EFSA-Q-2009-00119  Mepiquat (a)  UNITED KINGDOM  
EFSA-Q-2009-00118  Fuberidazole (a)  UNITED KINGDOM  
EFSA-Q-2009-00100  Chloridazon (a)  GERMANY  
EFSA-Q-2009-00135  Tralkoxydim (a)  UNITED KINGDOM  
EFSA-Q-2009-00052  Fluazifop-P (a)  FRANCE  
EFSA-Q-2009-00116  Fluazinam (a)  AUSTRIA 
EFSA-Q-2008-523  Deltametrin (b)  SWEDEN  
EFSA-Q-2010-00192  Methomyl (b)  UNITED KINGDOM  
EFSA-Q-2009-00191  Sulcotrione (b)  GERMANY  
EFSA-Q-2009-00129  Fenpyroximate (b)  GERMANY  
EFSA-Q-2009-00142  Aclonifen (b)  GERMANY  
EFSA-Q-2009-00159  Cymoxanil (b)  AUSTRIA 
EFSA-Q-2009-00151  Aluminium phosphide (b)  GERMANY  
EFSA-Q-2009-00173  Magnesium phosphide (b)  GERMANY  
EFSA-Q-2009-00157  Calcium phosphide (b)  GERMANY  
EFSA-Q-2010-00201  Sodium 5-nitroguaiacolate (b)  GREECE  
EFSA-Q-2010-00202  Sodium o-nitrophenolate (b)  GREECE  
EFSA-Q-2010-00203  Sodium p-nitrophenolate (b)  GREECE  
EFSA-Q-2009-00095  Zinc phosphide incl. phosphine 
(b)  GERMANY  
EFSA-Q-2012-00944  Phosphane (b)  GERMANY  
EFSA-Q-2009-00193  Triadimenol (b)  UNITED KINGDOM  
EFSA-Q-2009-00033  Bitertanol (b)  UNITED KINGDOM  
EFSA-Q-2010-00205  Tebufenpyrad (b)  GERMANY  
EFSA-Q-2010-00181  Chlormequat (b)  UNITED KINGDOM  
EFSA-Q-2008-643  Triclopyr  IRELAND  
EFSA-Q-2008-510  Chlorpyrifos-methyl  SPAIN  
EFSA-Q-2008-509  Chlorpyrifos  SPAIN  
EFSA-Q-2008-562  Imazalil  THE NETHERLANDS  
EFSA-Q-2010-00199  Propaquizafop  ITALY 
EFSA-Q-2010-00200  Quizalofop-P  FINLAND  
EFSA-Q-2009-00143  Imidacloprid  GERMANY  
EFSA-Q-2010-00180  Bensulfuron  ITALY 
EFSA-Q-2010-00191  Lufenuron  PORTUGAL  
EFSA-Q-2009-00044  Dithianon (c)  GREECE  
EFSA-Q-2009-00069  Prochloraz (d)  IRELAND  
EFSA-Q-2008-561  Glyphosate (e)  GERMANY  
EFSA-Q-2010-00183  Copper compounds  FRANCE  
EFSA-Q-2010-00208  Tri-allate  UNITED KINGDOM  
EFSA-Q-2010-00197  Penconazole  GERMANY  
EFSA-Q-2010-00189  Etofenprox  ITALY  
EFSA-Q-2010-00187  Dimethachlor  GERMANY  
EFSA-Q-2010-01068  2-Phenylphenol  SPAIN  
EFSA-Q-2009-00012  Triflumizole  THE NETHERLANDS  G/SPS/GEN/1494 
 
- 6 - 
 
  EFSA-Q-number (*) Active substance RMS 
EFSA-Q-2010-01077  Penoxsulam  ITALY  
EFSA-Q-2009-00026  Bromuconazole  BELGIUM 
EFSA-Q-2010-00209  Triflumuron  ITALY 
EFSA-Q-2009-00071  Pyridaben  THE NETHERLANDS  
EFSA-Q-2009-00049  Fenbuconazole  UNITED KINGDOM  
EFSA-Q-2009-00036  Carboxin  UNITED KINGDOM  
EFSA-Q-2009-00068  Pencycuron  THE NETHERLANDS  
EFSA-Q-2009-00087  Bromadiolone  SWEDEN  
EFSA-Q-2009-00038  Clethodim  THE NETHERLANDS  
EFSA-Q-2009-00051  Fenoxycarb  THE NETHERLANDS  
EFSA-Q-2009-00067  Paclobutrazol  UNITED KINGDOM  
EFSA-Q-2009-00041  Dazomet  BELGIUM  
EFSA-Q-2009-00059  Hexythiazox  FINLAND 
EFSA-Q-2009-00056  Flurochloridone  SPAIN  
EFSA-Q-2009-00075  Tebufenozide  GERMANY  
EFSA-Q-2009-00064  Myclobutanil  BELGIUM 
EFSA-Q-2011-00171  Bispyribac  ITALY  
EFSA-Q-2011-00172  Profoxydim  SPAIN  
EFSA-Q-2009-00076  Tefluthrin  GERMANY  
EFSA-Q-2012-00450  Metam  BELGIUM 
EFSA-Q-2012-00741  Fenpyrazamine  AUSTRIA  
EFSA-Q-2013-00277  Mandipropamid  AUSTRIA  
EFSA-Q-2013-00967  Tembotrione  AUSTRIA  
EFSA-Q-2009-00050  Fenbutatin oxide  BELGIUM 
 
 
(*) The EFSA-Q-number refers to the EFSA internal register of questions, published at: http://registerofquestions.efsa.europa.eu/ roqFrontend/ListOfQuestionsNoLogin?11 . Under this 
specific EFSA-Q-Number some more detailed information can be found. 
 (a): MRL review under the interim process was already finalised for this active substance.  
(b): Completeness check under the interim process wa s already finalised for this active substance; 
there is no longer any possibility to provide further data.  
(c): Although this active substance needs to be treated with high priority, EFSA needs to await 
finalisation of the confirmatory data process before proceeding with the MRL review. It is therefore likely that this substance will be moved further down the list. 
 
(d): Although this active substance needs to be treated with high priority, EFSA needs to await submission of data by the RMS before proceeding with the MRL review. It is therefore likely that 
this substance will be moved further down the list. 
 
(e): EFSA needs to await the outcome of the renewa l of the approval before proceeding with the 
MRL review for this active substance. It is therefore likely that this substance will be moved further 
down the list. 
 G/SPS/GEN/1494 
 
- 7 - 
 
  TABLE 2 
ACTIVE SUBSTANCES WHICH WILL BE REVIEWED UNDER THE " FUTURE " PROCESS 
Foreseen timeframe: the active substances listed in this table will be evaluated starting from the 
second quarter of 2017. The order corresponds to the planned order of evaluation of the active 
substances. It should be considered as indicative. In case of emerging priorities the order of 
evaluation of the substances may need to be amended.  
This table was updated on 8 March 2016. Non-EU countries authorities are invited to consult the 
following EFSA link to access always the most updated version: http://www.efsa.europa.eu/sites/d efault/files/event/140619ax1.pdf . 
 
EFSA-Q-number (*) Active substance RMS 
EFSA-Q-2008-590  Metiram (a)  ITALY  
EFSA-Q-2008-638  Thiram (a)  BELGIUM  
EFSA-Q-2008-648  Ziram (a)  BELGIUM 
EFSA-Q-2008-577  Mancozeb (a)  ITALY  
EFSA-Q-2008-578  Maneb (a)  ITALY  
EFSA-Q-2008-487  alpha-Cypermethrin (a)  BELGIUM 
EFSA-Q-2008-520  Cypermethrin (a)  BELGIUM 
EFSA-Q-2008-613  Propineb (a)  ITALY  
EFSA-Q-2009-00182  Pyrethrins (a)  ITALY  
EFSA-Q-2010-00211  zeta-Cypermethrin (a)  BELGIUM 
EFSA-Q-2008-527  Dimethoate  ITALY  
EFSA-Q-2008-498  beta-Cyfluthrin (a)  GERMANY  
EFSA-Q-2008-513  Clopyralid (a)  FINLAND  
EFSA-Q-2008-518  Cyfluthrin (a)  GERMANY  
EFSA-Q-2008-535  Ethoprophos (a)  ITALY  
EFSA-Q-2008-558  Fosthiazate (a)  GERMANY  
EFSA-Q-2008-575  Linuron (a)  ITALY  
EFSA-Q-2008-579  MCPA (a)  POLAND  
EFSA-Q-2008-580  MCPB (a)  POLAND  
EFSA-Q-2008-588  Methiocarb (a)  UNITED KINGDOM  
EFSA-Q-2008-592  Metribuzin (a)  ESTONIA  
EFSA-Q-2008-605  Phosmet (a)  SPAIN  
EFSA-Q-2008-624  Quinoxyfen (a)  UNITED KINGDOM 
EFSA-Q-2008-649  Zoxamide (a)  LATVIA  
EFSA-Q-2009-00021  Tricyclazole (a)  ITALY  
EFSA-Q-2009-00017  Beauveria brongniartii  GERMANY  
EFSA-Q-2009-00019  Potassium permanganate  SPAIN  
EFSA-Q-2009-00027  Chlorates (a)  FRANCE  
EFSA-Q-2009-00089  Fatty alcohols  ITALY  
EFSA-Q-2009-00094  Quassia  ITALY  
EFSA-Q-2009-00101  Clofentezine (a)  SPAIN  
EFSA-Q-2009-00102  Dicamba (a)  DANMARK  
EFSA-Q-2009-00103  Difenoconazole (a)  SPAIN  
EFSA-Q-2009-00104  Diflubenzuron (a)  GREECE  
EFSA-Q-2009-00106  Fenoxaprop-P (a)  AUSTRIA  
EFSA-Q-2009-00108  Imazaquin (a)  BELGIUM 
EFSA-Q-2009-00109  Lenacil (a)  BELGIUM 
EFSA-Q-2009-00113  Pyriproxyfen (a)  THE NETHERLANDS  
EFSA-Q-2009-00111  Oxadiazon (a)  ITALY  
EFSA-Q-2009-00112  Picloram (a)  POLAND  
EFSA-Q-2010-00193  Nicotine (a)  UNITED KINGDOM  
EFSA-Q-2009-00127  Epoxiconazole (a)  GERMANY  
EFSA-Q-2009-00148  2,5-Dichlorobenzoic acid 
methylester  GERMANY  
EFSA-Q-2009-00160  Denathonium benzoate  PORTUGAL  G/SPS/GEN/1494 
 
- 8 - 
 
  EFSA-Q-number (*) Active substance RMS 
EFSA-Q-2009-00174  MetamItalyron (a)  UNITED KINGDOM  
EFSA-Q-2009-00150  Aluminium ammonium sulfate  PORTUGAL  
EFSA-Q-2009-00152  Aluminium silicate  HUNGARY  
EFSA-Q-2009-00189  Sodium aluminium silicate  HUNGARY  
EFSA-Q-2009-00190  Sodium hypochlorite  THE NETHERLANDS  
EFSA-Q-2010-00182  Chlorsulfuron  GREECE  
EFSA-Q-2010-00186  Difenacoum  FINLAND  
EFSA-Q-2010-00207  Tetraconazole (a)  ITALY  
EFSA-Q-2010-01070  Cyflufenamid  UNITED KINGDOM  
EFSA-Q-2010-01075  Malathion  UNITED KINGDOM  
EFSA-Q-2010-01073  Fluopicolide  UNITED KINGDOM  
EFSA-Q-2010-01078  Proquinazid  UNITED KINGDOM  
EFSA-Q-2010-01079  Spirodiclofen  THE NETHERLANDS  
EFSA-Q-2010-01080  Sulfuryl fluoride (a)  UNITED KINGDOM  
EFSA-Q-2009-00029  Napropamide  DANMARK  
EFSA-Q-2009-00018  Buprofezin (a)  UNITED KINGDOM  
EFSA-Q-2009-00072  Quinmerac (a)  UNITED KINGDOM  
EFSA-Q-2009-00084  Aluminium sulphate  THE NETHERLANDS  
EFSA-Q-2009-00034  Bupirimate  THE NETHERLANDS  
EFSA-Q-2009-00040  Cyproconazole  IRELAND  
EFSA-Q-2009-00047  Etridiazole  THE NETHERLANDS  
EFSA-Q-2009-00048  Fenazaquin  GREECE  
EFSA-Q-2009-00054  Fluometuron  GREECE 
EFSA-Q-2009-00074  tau-Fluvalinate  DANMARK  
EFSA-Q-2009-00039  Cycloxydim  AUSTRIA 
EFSA-Q-2009-00060  Hymexazol  FINLAND  
EFSA-Q-2009-00073  Sintofen  FRANCE  
EFSA-Q-2009-00085  Azadirachtin (a)  GERMANY  
EFSA-Q-2009-00042  Diclofop (a)  FRANCE  
EFSA-Q-2009-00061  Isoxaben (a)  SWEDEN  
EFSA-Q-2010-01082  Triazoxide  UNITED KINGDOM  
EFSA-Q-2009-00053  Flufenoxuron  FRANCE  
EFSA-Q-2011-01093  8-Hydroxyquinoline  SPAIN  
EFSA-Q-2009-00055  Fluquinconazole  IRELAND  
EFSA-Q-2009-00066  Oxyfluorfen  SPAIN  
EFSA-Q-2009-00077  Terbuthylazine  UNITED KINGDOM  
EFSA-Q-2013-00803  Novaluron  UNITED KINGDOM  
EFSA-Q-2012-00690  Fluxapyroxad  UNITED KINGDOM  
EFSA-Q-2010-00185  Didecyldimethylammonium 
chloride (a)  THE NETHERLANDS  
EFSA-Q-2012-00943  Isopyrazam  UNITED KINGDOM  
EFSA-Q-2013-00520  Cyflumetofen (a)  THE NETHERLANDS  
EFSA-Q-2013-00279  Ametoctradin  THE NETHERLANDS  
EFSA-Q-2013-00344  Bixafen  UNITED KINGDOM  
EFSA-Q-2013-00349  Potassium phosphonates  FRANCE  
EFSA-Q-2013-00351  Spiromesifen  UNITED KINGDOM  
EFSA-Q-2013-00345  Halosulfuron-methyl (a)  ITALY  
EFSA-Q-2013-00778  Disodium phosphonate  FRANCE  
EFSA-Q-2013-00775  Fluopyram  GERMANY  
EFSA-Q-2013-00879  Penflufen  UNITED KINGDOM  
EFSA-Q-2013-00779  Pyriofenone  UNITED KINGDOM  
EFSA-Q-2013-00776  Sedaxane  FRANCE  
EFSA-Q-2014-00122  Potassium thiocyanate  THE NETHERLANDS  
EFSA-Q-2014-00204  Potassium iodide  THE NETHERLANDS  
EFSA-Q-2013-00909  Benalaxyl-M  PORTUGAL  
EFSA-Q-2013-00965  Chlorantraniliprole  IRELAND  
EFSA-Q-2013-00777  Emamectin  THE NETHERLANDS  
EFSA-Q-2013-00966  Penthiopyrad  UNITED KINGDOM  
EFSA-Q-2013-00911  Spirotetramat  AUSTRIA  
EFSA-Q-2013-00910  Pyroxsulam (a)  UNITED KINGDOM  
EFSA-Q-2014-00212  Amisulbrom  UNITED KINGDOM  G/SPS/GEN/1494 
 
- 9 - 
 
  EFSA-Q-number (*) Active substance RMS 
EFSA-Q-2014-00206  Pyridalyl  THE NETHERLANDS  
EFSA-Q-2014-00205  Spinetoram  UNITED KINGDOM  
EFSA-Q-2014-00208  Thiencarbazone  UNITED KINGDOM  
EFSA-Q-2014-00211  1,4-Dimethylnaphthalene (a)  THE NETHERLANDS  
EFSA-Q-2014-00207  Valifenalate (a)  HUNGARY  
EFSA-Q-2014-00360  Acequinocyl  THE NETHERLANDS  
EFSA-Q-2014-00454  Flubendiamide  GREECE 
EFSA-Q-2014-00374  Ipconazole  UNITED KINGDOM  
EFSA-Q-2014-00594  Aminopyralid  UNITED KINGDOM  
EFSA-Q-2014-00596  Metaflumizone (a)  UNITED KINGDOM  
EFSA-Q-2014-00593  Metobromuron (a)  FRANCE  
EFSA-Q-2015-00080  Meptyldinocap  UNITED KINGDOM  
EFSA-Q-2015-00068  Chromafenozide (a)  HUNGARY  
EFSA-Q-2015-00071  Gamma-cyhalothrin (a)  UNITED KINGDOM  
EFSA-Q-2015-00476  Halauxyfen-methyl  UNITED KINGDOM  
EFSA-Q-2015-00485  Sulfoxaflor  IRELAND  
Not yet attributed.  3-decen-2-one (b)  THE NETHERLANDS  
Not yet attributed.  Beta-cypermethrin (b)  UNITED KINGDOM  
Not yet attributed.  Cyantraniliprole (b)  UNITED KINGDOM  
Not yet attributed.  Ethametsulfuron (b)  UNITED KINGDOM  
Not yet attributed.  Flumetralin (b)  HUNGARY 
Not yet attributed.  Flutianil (b)  UNITED KINGDOM  
Not yet attributed.  Orthosulfamuron (b)  ITALY  
Not yet attributed.  Pinoxaden (b)  UNITED KINGDOM  
Not yet attributed.  Topramezone  FRANCE  
 
 (*) The EFSA-Q-number refers to the EFSA internal register of questions, published at: 
http://registerofquestions.efsa.europa.eu/ roqFrontend/ListOfQuestionsNoLogin?11 . Under this 
specific EFSA-Q-Number some more detailed information can be found. 
 (a): EFSA needs to await the outcome of another assessment before proceeding with the MRL 
review for this active substance (renewal of the approval, confirmatory data for the approval, 
assessments in other food sector area,…). It is therefore likely that this substance will be moved further down the list. 
 
(b): A decision on approval or non-approval of these active substances was not yet taken; they were therefore not yet formally included in the MRL review program. However, as these 
substances are pending a decision by the European Commission and Member States, it is likely 
that they substances will be added to the MRL review program in the future.  
__________